| GTO ID | GTC0960 |
| Trial ID | ChiCTR2100054012 |
| Disease | Multiple Myeloma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | The Safety and Efficacy of SKB394-B Therapy in Relapsed or Refractory Multiple Myeloma |
| Year | 2021 |
| Country | China |
| Company sponsor | Cancer Hospital Affiliated to Guangxi Medical University |
| Cohort 1 | |||||||
|
|||||||